![]() |
市場調查報告書
商品編碼
1954933
全球生物光子學市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)Biophotonics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球生物光子學市場規模為661.5億美元,預計將從2026年的703.1億美元成長到2034年的1174.9億美元,預測期內複合年增長率(CAGR)為6.63%。亞太地區在全球生物光子學市場中佔主導地位,預計到2025年將佔41.79%的市場佔有率,這主要得益於不斷增長的醫療需求、活躍的生命科學研究活動以及先進感測技術的快速普及。
生物光子學是一門將光子學、生物學和醫學結合的跨學科。它涵蓋成像系統、雷射、光纖和光譜儀等技術,廣泛應用於疾病診斷、醫學研究、治療和農業分析。不斷增加的研究投入和用於疾病早期檢測的生物感測器的普及,正在擴大該市場的長期潛力。 市場概覽 由於醫療和生命科學領域對非侵入性診斷方法和即時監測解決方案的需求不斷增長,生物光子學產業正蓬勃發展。腫瘤學、神經病學、心臟病學和傳染病檢測等領域的應用正在推動先進光子工具的普及。 新冠疫情初期,由於基礎設施不足和人們對傳染病監測的認識不足,抑制了市場成長。然而,隨著疫情後的復甦,調查活動加速開展,對便攜式、快速反應的感測和監測設備的需求日益增長。這種轉變正在增強生物光子學市場的長期前景。
生物光子學市場趨勢
人工智慧與機器學習在生命科學領域的融合
人工智慧 (AI) 和機器學習 (ML) 的融合是塑造生物光子學市場的關鍵趨勢。人工智慧軟體平台與先進光子感測器的結合正在提高診斷準確性,並實現更快的疾病檢測。
基於大型生物醫學資料集訓練的機器學習模型能夠對影像和光譜分析結果進行精確解讀。小型化健康監測系統和人工智慧診斷工具的日益普及預計將進一步加速生物光子學技術在醫療和農業研究領域的應用。
市場成長驅動因素
技術進步與安全產品需求
全球醫療保健支出不斷增長,推動了成像、顯微鏡和光譜技術的持續進步。個人和商業醫療保健領域對非侵入性、即時、精準診斷設備的需求是主要的成長驅動因素。
例如,2024年1月,卡爾蔡司發表了Lattice SIM 3和Lattice SIM 5超解析度顯微鏡,旨在克服傳統光學顯微鏡的限制。此類創新正在加速生物光子學解決方案在全球的應用。
限制因子
高成本與監理挑戰
高昂的初始投資成本和複雜的製造流程是市場成長的挑戰。生物光子學設備需要嚴格的監管合規和認證,這增加了製造商的資金需求。
此外,來自新創企業的競爭加劇以及主要參與者的業務重組可能會限制產品多樣化。例如,濱松光子學於2024年5月出售了其子公司NKT Photonics以精簡運營,反映了產業重組的趨勢。
市場區隔分析
依產品劃分
依產品劃分,市場可分為成像系統、雷射、光纖及其他(光譜儀等)。預計到 2026 年,雷射技術將佔市場 35.87% 的佔有率,成為推動市場成長的主要動力,這主要得益於其在癌症治療、光療和皮膚病治療等領域的廣泛應用。
由於在疾病早期檢測和醫療監測領域的應用不斷擴展,影像系統預計將實現最高的複合年增長率 (CAGR)。光纖和光譜儀在農業分析和病原體檢測領域的應用也將繼續支撐市場成長。
依應用領域劃分
依應用領域劃分,市場可分為生物感測、活細胞成像、光學感測與檢測、光合作用評估等領域。預計到 2026 年,生物感測領域將佔 37.73% 的市場佔有率,這主要得益於生命科學研究投入的增加。
區域概覽
亞太地區預計將引領市場,2025年市場規模將達276.5億美元,2026年將達298.9億美元。其中,中國預計將達到145.7億美元,日本59.9億美元,印度42.9億美元,醫療保健和農業物聯網領域的投資將推動市場成長。
北美預計將維持穩定成長,美國市場預計到2026年將達到49億美元。歐洲市場也呈現穩定成長態勢,德國預計2026年將達到46.6億美元,英國將達36.8億美元。
主要公司
主要公司包括濱松光子學、奧林巴斯、蔡司、賽默飛世爾科技、珀金埃爾默、Bio-Rad Laboratories和島津。 Corporation、BD、Lumenis 和 Zecotec Photonics。這些公司正專注於研發投入、先進產品開發和策略性產品發布,以鞏固其市場地位。
The global biophotonics market size was valued at USD 66.15 billion in 2025 and is projected to grow from USD 70.31 billion in 2026 to USD 117.49 billion by 2034, exhibiting a CAGR of 6.63% during the forecast period. Asia Pacific dominated the global biophotonics market with a 41.79% share in 2025, supported by rising healthcare demand, strong life science research activity, and rapid adoption of advanced sensing technologies.
Biophotonics is an interdisciplinary field that combines photonics with biology and medicine. It includes technologies such as imaging systems, lasers, fiber optics, and spectrometers, which are widely used for disease diagnosis, medical research, therapy, and agricultural analytics. Increasing research investments and the growing use of biological sensors for early disease detection are expanding the long-term potential of the market.
MARKET OVERVIEW
The biophotonics industry is gaining momentum due to rising demand for non-invasive diagnostics and real-time monitoring solutions in healthcare and life sciences. Applications in oncology, neurology, cardiology, and infectious disease detection are driving the adoption of advanced photonic tools.
The COVID-19 pandemic initially restrained market growth due to limited infrastructure and lack of awareness regarding communicable disease monitoring. However, post-pandemic recovery has accelerated research activities and increased demand for portable, quick-response sensing and monitoring devices. This shift has strengthened the long-term outlook of the biophotonics market.
BIOPHOTONICS MARKET TRENDS
Integration of AI and ML in Life Sciences
The integration of Artificial Intelligence (AI) and Machine Learning (ML) is a key trend shaping the biophotonics market. AI-enabled software platforms combined with advanced photonic sensors are improving diagnostic accuracy and enabling faster disease detection.
Machine learning models trained on large biomedical datasets allow precise interpretation of imaging and spectroscopy results. The growing use of miniaturized health monitoring systems and AI-powered diagnostic tools is expected to further enhance the adoption of biophotonics technologies across healthcare and agricultural research applications.
MARKET GROWTH FACTORS
Technological Advancements and Demand for Safe Products
Rising global healthcare expenditure is driving continuous technological advancements in imaging, microscopy, and spectroscopy. The demand for non-invasive, real-time, and accurate diagnostic devices across personal and commercial healthcare settings is a major growth driver.
For instance, in January 2024, Carl Zeiss AG launched Lattice SIM 3 and Lattice SIM 5 superresolution microscopes, designed to overcome the limitations of traditional light microscopy. Such innovations are accelerating the adoption of biophotonics solutions worldwide.
RESTRAINING FACTORS
High Costs and Regulatory Challenges
High initial investment costs and complex manufacturing processes pose challenges to market growth. Biophotonic devices require strict regulatory compliance and certification, increasing capital requirements for manufacturers.
Additionally, growing competition from startups and restructuring initiatives by major players may restrict product diversification. For example, in May 2024, Hamamatsu Photonics sold its subsidiary NKT Photonics to streamline operations, reflecting restructuring trends within the industry.
MARKET SEGMENTATION ANALYSIS
By Product
Based on products, the market is segmented into imaging systems, lasers, fiber optics, and others (spectrometers). The laser segment dominated the market with a 35.87% share in 2026, driven by its extensive use in cancer treatment, light therapy, and dermatological procedures.
Imaging systems are expected to register the highest CAGR due to their increasing application in early disease detection and medical monitoring. Fiber optics and spectrometers continue to support market growth through applications in agriculture analytics and pathogen detection.
By Application
By application, the market includes biological sensing & process, live cell imaging, optical sensing & detection, photosynthesis evaluation, and others. The biological sensing & process segment held a 37.73% share in 2026, supported by rising investments in life science research.
REGIONAL INSIGHTS
Asia Pacific led the market with a valuation of USD 27.65 billion in 2025, reaching USD 29.89 billion in 2026. China is projected to reach USD 14.57 billion, Japan USD 5.99 billion, and India USD 4.29 billion by 2026, driven by healthcare and agro-IoT investments.
North America is projected to grow steadily, with the U.S. market reaching USD 4.9 billion by 2026. Europe shows stable growth, with Germany projected at USD 4.66 billion and the UK at USD 3.68 billion by 2026.
KEY INDUSTRY PLAYERS
Key players include Hamamatsu Photonics, Olympus Corporation, Zeiss, Thermo Fisher Scientific, PerkinElmer, Bio-Rad Laboratories, Shimadzu, BD, Lumenis Ltd., and Zecotek Photonics. These companies focus on R&D investments, advanced product development, and strategic launches to strengthen market positioning.
Conclusion
The global biophotonics market is expected to grow from USD 66.15 billion in 2025 to USD 117.49 billion by 2034, driven by technological advancements, AI integration, and rising demand for non-invasive diagnostic solutions. While high costs and regulatory challenges remain, increasing investments in healthcare, life science research, and agricultural analytics are supporting sustained market growth. Asia Pacific will continue to lead the market, while innovation and product development by key players will shape the future of the biophotonics industry over the forecast period.
Segmentation By Products
By Application
By Region